Update on the Management of Gastroenteropancreatic Neuroendocrine Tumors With Emphasis on the Role of Imaging

被引：33

作者：

Kim, Kyung Won ^{[1
,2
,3
]}

Krajewski, Katherine M. ^{[1
]}

Nishino, Mizuki ^{[1
]}

Jagannathan, Jyothi P. ^{[1
]}

Shinagare, Atul B. ^{[1
]}

Tirumani, Sree Harsha ^{[1
]}

Ramaiya, Nikhil H. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea

[3] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea

来源：

AMERICAN JOURNAL OF ROENTGENOLOGY | 2013年 / 201卷 / 04期

基金：

美国国家卫生研究院;

关键词：

gastroenteropancreatic neuroendocrine tumor; guidelines; molecular targeted therapy; CLINICAL-PRACTICE GUIDELINES; CARCINOID-TUMORS; SOMATOSTATIN; METASTASIS; NEOPLASMS; DIAGNOSIS; ERA;

D O I：

10.2214/AJR.12.10240

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

OBJECTIVE. The purposes of this article are to review the current management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) based on the 2012 National Comprehensive Cancer Network guidelines and to describe the role of imaging in a multidisciplinary approach. CONCLUSION. The management of GEP-NETs has become complex, requiring a multidisciplinary approach. The World Health Organization classification of GEP-NETs has been revised; the U.S. Food and Drug Administration has approved molecular targeted agents (sunitinib, everolimus) for the treatment of pancreatic NETs; and the National Comprehensive Cancer Network clinical practice guidelines have been updated.

引用

页码：811 / 824

页数：14

共 36 条

[1] Incidence and management of mTOR inhibitor-associated pneumonitis in patients with metastatic renal cell carcinoma [J].

Albiges, L. ;

Chamming's, F. ;

Duclos, B. ;

Stern, M. ;

Motzer, R. J. ;

Ravaud, A. ;

Camus, P. .

ANNALS OF ONCOLOGY, 2012, 23 (08) :1943-1953

[2] Neuroendocrine Neoplasms of the Gastroenteropancreatic System: Pathology and Classification [J].

Anlauf, M. .

HORMONE AND METABOLIC RESEARCH, 2011, 43 (12) :825-831

[3] Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin [J].

Auernhammer, Christoph J. ;

Goeke, Burkhard .

GUT, 2011, 60 (07) :1009-1021

[4] Pancreatic neuroendocrine neoplasms: diagnosis and management [J].

Balachandran, Aparna ;

Tamm, Eric P. ;

Bhosale, Priya R. ;

Patnana, Madhavi ;

Vikram, Raghu ;

Fleming, Jason B. ;

Katz, Matthew H. ;

Charnsangavej, Chuslip .

ABDOMINAL IMAGING, 2013, 38 (02) :342-357

[5] Neuroendocrine Pancreatic Tumors: Guidelines for Management and Update [J].

Burns, William R. ;

Edil, Barish H. .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (01) :24-34

[6] What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents [J].

Sona A. Chikarmane ;

Bharti Khurana ;

Katherine M. Krajewski ;

Atul B. Shinagare ;

Stephanie Howard ;

Aaron Sodickson ;

Jyothi Jagannathan ;

Nikhil Ramaiya .

Emergency Radiology, 2012, 19 (6) :535-546

[7] Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria [J].

Choi, Haesun ;

Charnsangavej, Chuslip ;

Faria, Silvana C. ;

Macapinlac, Homer A. ;

Burgess, Michael A. ;

Patel, Shreyaskumar R. ;

Chen, Lei L. ;

Podoloff, Donald A. ;

Benjamin, Robert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1753-1759

[8] New Strategies for Advanced Neuroendocrine Tumors in the Era of Targeted Therapy [J].

Dong, Mei ;

Phan, Alexandria T. ;

Yao, James C. .

CLINICAL CANCER RESEARCH, 2012, 18 (07) :1830-1836

[9]

Edge S.B., 2010, AJCC cancer staging manual, V649

[10] The role of somatostatin and dopamine D2 receptors in endocrine tumors [J].

Gatto, Federico ;

Hofland, Leo J. .

← 1 2 3 4 →